Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Sales (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Return on Sales data on record, last reported at 3.63% in Q3 2025.

  • For Q3 2025, Return on Sales fell 37.0% year-over-year to 3.63%; the TTM value through Sep 2025 reached 5.86%, down 511.0%, while the annual FY2024 figure was 0.62%, N/A changed from the prior year.
  • Return on Sales reached 3.63% in Q3 2025 per GOSS's latest filing, down from 3.33% in the prior quarter.
  • Across five years, Return on Sales topped out at 53.61% in Q1 2024 and bottomed at 3.97% in Q1 2025.
  • Average Return on Sales over 4 years is 12.31%, with a median of 14.53% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 3908bps in 2024, then crashed -5758bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 16.55% in 2022, then soared by 64bps to 27.08% in 2023, then tumbled by -84bps to 4.36% in 2024, then plummeted by -183bps to 3.63% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 3.63% in Q3 2025, 3.33% in Q2 2025, and 3.97% in Q1 2025.